The formation of subsequent inter-firm R&D partnerships between large pharmaceutical companies and small, entrepreneurial biotechnology firms - How important is inter-organisational trust?

J. Hagedoorn*, A.H.W.M. Roijakkers, H.L. van Kranenburg

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


This paper analyses the role of inter-organisational trust in pharmaceutical biotechnology, all industry characterised by a strong dual market structure. Our main finding is that repeated ties in pairs of large pharmaceutical companies and small, entrepreneurial biotechnology firms, which indicate inter-organisational trust, have a negative effect on Subsequent partnering. An explanation for this result is found in specific conditions for R&D partnering in this high-technology dual market structure. Partnerships between a small number of very large companies and a large group of dependent small companies are not characterised by Mutual dependence and inter-organisational trust.
Original languageEnglish
Pages (from-to)81-92
JournalInternational Journal of Technology Management
Issue number1/2
Publication statusPublished - 1 Jan 2008

Cite this